Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Deficits in preference-based health-related quality of life after complications associated with tibial fracture.

Gitajn IL, Titus AJ, Tosteson AN, Sprague S, Jeray K, Petrisor B, Swiontkowski M, Bhandari M, Slobogean G.

Bone Joint J. 2018 Sep;100-B(9):1227-1233. doi: 10.1302/0301-620X.100B9.BJJ-2017-1488.R1.

PMID:
30168778
2.

Medicare Utilization and Spending Among Nurses Compared with the General United States Population.

Kapadia NS, Austin AM, Carmichael DQ, Wang Q, Erekson ED, Feskanich D, Grodstein F, Tosteson ANA, Bynum JPW.

J Womens Health (Larchmt). 2018 Aug 17. doi: 10.1089/jwh.2017.6802. [Epub ahead of print]

PMID:
30118370
3.

Multi-level Influences on Breast Cancer Screening in Primary Care.

Onega T, Tosteson TD, Weiss J, Haas JS, Goodrich M, DiFlorio R, Brackett C, Clark C, Harris K, Tosteson ANA.

J Gen Intern Med. 2018 Aug 3. doi: 10.1007/s11606-018-4560-1. [Epub ahead of print]

PMID:
30076569
4.

How Do Women View Risk-Based Mammography Screening? A Qualitative Study.

He X, Schifferdecker KE, Ozanne EM, Tosteson ANA, Woloshin S, Schwartz LM.

J Gen Intern Med. 2018 Jul 31. doi: 10.1007/s11606-018-4601-9. [Epub ahead of print]

PMID:
30066118
5.

The effect of mammography screening regimen on incidence-based breast cancer mortality.

Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK.

J Med Screen. 2018 Jul 26:969141318780152. doi: 10.1177/0969141318780152. [Epub ahead of print]

PMID:
30049249
6.

Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions.

Titus LJ, Reisch LM, Tosteson ANA, Nelson HD, Frederick PD, Carney PA, Barnhill RL, Elder DE, Weinstock MA, Piepkorn MW, Elmore JG.

Am J Clin Pathol. 2018 Aug 30;150(4):338-345. doi: 10.1093/ajcp/aqy057.

PMID:
30007278
7.

Long-Term Results of Surgery Compared with Nonoperative Treatment for Lumbar Degenerative Spondylolisthesis in the Spine Patient Outcomes Research Trial (SPORT).

Abdu WA, Sacks OA, Tosteson ANA, Zhao W, Tosteson TD, Morgan TS, Pearson A, Weinstein JN, Lurie JD.

Spine (Phila Pa 1976). 2018 Apr 12. doi: 10.1097/BRS.0000000000002682. [Epub ahead of print]

PMID:
29652786
8.

Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.

Gareen IF, Black WC, Tosteson TD, Wang Q, Sicks JD, Tosteson ANA.

Med Care. 2018 May;56(5):403-409. doi: 10.1097/MLR.0000000000000900.

PMID:
29613874
9.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30. Review.

10.

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Jul;79(1):52-59.e5. doi: 10.1016/j.jaad.2018.02.070. Epub 2018 Mar 7.

PMID:
29524584
11.

Preoperative breast MRI and mortality in older women with breast cancer.

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA.

Breast Cancer Res Treat. 2018 Jul;170(1):149-157. doi: 10.1007/s10549-018-4732-z. Epub 2018 Mar 7.

PMID:
29516372
12.

Cost-effectiveness of mammography from a publicly funded health care system perspective.

Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ.

CMAJ Open. 2018 Feb 8;6(1):E77-E86. doi: 10.9778/cmajo.20170106.

13.

What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.

Durand MA, Yen RW, O'Malley AJ, Politi MC, Dhage S, Rosenkranz K, Weichman K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Song J, Acosta J, Mir N, Elwyn G.

BMC Public Health. 2018 Feb 13;18(1):241. doi: 10.1186/s12889-018-5109-2.

14.

Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.

PMID:
29435556
15.

Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B.

Acad Radiol. 2018 Sep;25(9):1118-1127. doi: 10.1016/j.acra.2017.12.028. Epub 2018 Feb 9.

PMID:
29433892
16.

Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI.

J Womens Health (Larchmt). 2018 Jun;27(6):748-754. doi: 10.1089/jwh.2017.6623. Epub 2018 Jan 17.

PMID:
29341851
17.

Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer.

Bronson MR, Kapadia NS, Austin AM, Wang Q, Feskanich D, Bynum JPW, Grodstein F, Tosteson ANA.

Med Care. 2018 Jan 12. doi: 10.1097/MLR.0000000000000875. [Epub ahead of print]

PMID:
29334524
18.

Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.

Svedbom A, Borgström F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M, Uusküla A, Lember M, Kallikorm R, Lesnyak O, McCloskey E, Ershova O, Sanders KM, Silverman S, Tamulaitiene M, Thomas T, Tosteson ANA, Jönsson B, Kanis JA.

Qual Life Res. 2018 Mar;27(3):707-716. doi: 10.1007/s11136-017-1748-5. Epub 2017 Dec 12.

PMID:
29235059
19.

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.

Svedbom A, Borgstöm F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M, Kallikorm R, Lember M, Lesnyak O, McCloskey E, Sanders KM, Silverman S, Solodovnikov A, Tamulaitiene M, Thomas T, Toroptsova N, Uusküla A, Tosteson ANA, Jönsson B, Kanis JA.

Osteoporos Int. 2018 Mar;29(3):557-566. doi: 10.1007/s00198-017-4317-4. Epub 2017 Dec 11.

PMID:
29230511
20.

Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T.

J Gen Intern Med. 2018 Mar;33(3):275-283. doi: 10.1007/s11606-017-4224-6. Epub 2017 Dec 6.

PMID:
29214373
21.

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL.

Breast Cancer Res Treat. 2018 Feb;168(1):229-239. doi: 10.1007/s10549-017-4582-0. Epub 2017 Nov 28.

PMID:
29185118
22.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

PMID:
29150480
23.

Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

PMID:
29127715
24.

Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.

Lott JP, Boudreau DM, Barnhill RL, Weinstock MA, Knopp E, Piepkorn MW, Elder DE, Knezevich SR, Baer A, Tosteson ANA, Elmore JG.

JAMA Dermatol. 2018 Jan 1;154(1):24-29. doi: 10.1001/jamadermatol.2017.4060.

PMID:
29094145
25.

Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, Pepe M, Geller B, Carney PA, Onega T, Allison KH, Elmore JG, Weaver DL.

Breast Cancer Res Treat. 2018 Jan;167(1):195-203. doi: 10.1007/s10549-017-4432-0. Epub 2017 Sep 6.

PMID:
28879558
26.

Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.

PMID:
28858936
27.

Understanding the value of minimally invasive procedures for the treatment of lumbar spinal stenosis: the case of interspinous spacer devices.

Tapp SJ, Martin BI, Tosteson TD, Lurie JD, Weinstein MC, Deyo RA, Mirza SK, Tosteson ANA.

Spine J. 2018 Apr;18(4):584-592. doi: 10.1016/j.spinee.2017.08.246. Epub 2017 Aug 25.

PMID:
28847740
28.

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.

29.

The diagnostic challenge of low-grade ductal carcinoma in situ.

Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV, Pepe MS, Elmore JG.

Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.

30.

Characteristics associated with requests by pathologists for second opinions on breast biopsies.

Geller BM, Nelson HD, Weaver DL, Frederick PD, Allison KH, Onega T, Carney PA, Tosteson ANA, Elmore JG.

J Clin Pathol. 2017 Nov;70(11):947-953. doi: 10.1136/jclinpath-2016-204231. Epub 2017 May 2.

31.

A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis.

Elmore JG, Longton GM, Pepe MS, Carney PA, Nelson HD, Allison KH, Geller BM, Onega T, Tosteson AN, Mercan E, Shapiro LG, Brunyé TT, Morgan TR, Weaver DL.

J Pathol Inform. 2017 Mar 10;8:12. doi: 10.4103/2153-3539.201920. eCollection 2017.

32.

Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type.

Clark CR, Tosteson TD, Tosteson ANA, Onega T, Weiss JE, Harris KA, Haas JS.

Cancer Med. 2017 May;6(5):1102-1107. doi: 10.1002/cam4.1036. Epub 2017 Apr 4.

33.

Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.

Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Weinstock MA, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Sep;177(3):845-853. doi: 10.1111/bjd.15530. Epub 2017 Jul 9.

PMID:
28369774
34.

Falling Down on the Job: Evaluation and Treatment of Fall Risk Among Older Adults With Upper Extremity Fragility Fractures.

McDonough CM, Colla CH, Carmichael D, Tosteson ANA, Tosteson TD, Bell JE, Cantu RV, Lurie JD, Bynum JPW.

Phys Ther. 2017 Mar 1;97(3):280-289. doi: 10.1093/ptj/pzx009.

35.

Where Is the Geriatrician?-Reply.

Bynum J, Munson J, Tosteson AN.

JAMA Intern Med. 2017 Mar 1;177(3):442-443. doi: 10.1001/jamainternmed.2016.8856. No abstract available.

PMID:
28264119
36.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

37.

Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.

Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T.

J Womens Health (Larchmt). 2017 Aug;26(8):820-827. doi: 10.1089/jwh.2016.6076. Epub 2017 Feb 8.

38.

Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.

Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, Harris K, Pyle S, Tosteson AN.

Am J Manag Care. 2017 Jan;23(1):35-40.

39.

Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients.

Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Gen Intern Med. 2017 Apr;32(4):449-457. doi: 10.1007/s11606-016-3973-y. Epub 2017 Jan 9.

40.

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

41.

Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?

Jackson SL, Frederick PD, Pepe MS, Nelson HD, Weaver DL, Allison KH, Carney PA, Geller BM, Tosteson AN, Onega T, Elmore JG.

Ann Surg Oncol. 2017 May;24(5):1234-1241. doi: 10.1245/s10434-016-5695-0. Epub 2016 Dec 2.

42.

Medical home transformation and breast cancer screening.

Baughman AW, Brawarsky P, Onega T, Tosteson TD, Wang Q, Tosteson AN, Haas JS.

Am J Manag Care. 2016 Nov 1;22(11):e382-e388.

43.

Annual Combined Mammography and Tomosynthesis Screening: Is It Really Cost-Effective?

Lee CI, Lee JM, Tosteson AN.

AJR Am J Roentgenol. 2016 Nov;207(5):1156-1158. Epub 2016 Aug 17.

PMID:
27533738
44.

Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations.

Chang CH, Bynum JP, Onega T, Colla CH, Lurie JD, Tosteson AN.

J Womens Health (Larchmt). 2016 Oct;25(10):1030-1037. Epub 2016 Jul 18.

45.

Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy.

Weiss JE, Goodrich M, Harris KA, Chicoine RE, Synnestvedt MB, Pyle SJ, Chen JS, Herschorn SD, Beaber EF, Haas JS, Tosteson AN, Onega T; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Am Coll Radiol. 2017 Feb;14(2):198-207.e2. doi: 10.1016/j.jacr.2016.08.017. Epub 2016 Oct 13.

46.

Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium.

Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE.

Breast Cancer Res Treat. 2016 Nov;160(2):323-331. Epub 2016 Sep 24.

47.

A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care.

Haas JS, Baer HJ, Eibensteiner K, Klinger EV, St Hubert S, Getty G, Brawarsky P, Orav EJ, Onega T, Tosteson AN, Bates DW, Colditz G.

Am J Prev Med. 2017 Jan;52(1):100-105. doi: 10.1016/j.amepre.2016.07.013. Epub 2016 Sep 14.

48.

Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.

Weinstock MA, Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Pearson L, Piepkorn M, Barnhill RL, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Apr;176(4):949-954. doi: 10.1111/bjd.15077. Epub 2017 Mar 1.

49.

Patterns of Prescription Drug Use Before and After Fragility Fracture.

Munson JC, Bynum JP, Bell JE, Cantu R, McDonough C, Wang Q, Tosteson TD, Tosteson AN.

JAMA Intern Med. 2016 Oct 1;176(10):1531-1538. doi: 10.1001/jamainternmed.2016.4814.

50.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.

Supplemental Content

Loading ...
Support Center